Sanesco International

Sanesco International

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Sanesco International is a private, commercial-stage company that has developed a service and product platform centered on neuroendocrine diagnostics and personalized wellness. Its core offering is the NeuroWellness Program, which provides healthcare providers with tools like neurotransmitter and hormone testing to identify imbalances and recommend targeted nutritional formulas. With nearly two decades of operation, Sanesco targets the growing market for integrative and personalized medicine, serving practitioners rather than direct-to-consumer. The company's business model blends diagnostic services with supplement-based product sales.

NeuroscienceMetabolic HealthEndocrinology

Technology Platform

Integrated diagnostic and therapeutic platform focusing on HPA axis assessment. Includes urine-based neurotransmitter testing, saliva-based hormone testing, and algorithmic recommendation of proprietary nutraceutical formulas (NeuroWellness Formulas) based on test results.

Opportunities

The company is positioned in the high-growth integrative and personalized medicine market, with increasing demand from practitioners for objective tools to manage stress-related and neuroendocrine conditions.
Its integrated test-and-treat model creates recurring revenue and strong practitioner loyalty.

Risk Factors

Key risks include regulatory scrutiny of laboratory-developed tests and supplement claims, scientific debate over the clinical utility of urinary neurotransmitter testing, and intense competition in the functional medicine diagnostics and nutraceutical space.

Competitive Landscape

Sanesco competes with other functional medicine diagnostic labs (e.g., Genova Diagnostics, Doctor's Data) and numerous nutraceutical companies. Its differentiation lies in its specific focus on the HPA axis and its closed-loop system of testing paired with targeted formula recommendations.